The global cryoglobulinemia treatment market is poised for significant growth, with an expected market value of US$ 496 ...

Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (“Teva”) agreed to pay $450 million to resolve two matters that allege ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Here is how Teva Pharmaceutical Industries Ltd. (TEVA) and Addus HomeCare (ADUS) have performed compared to their sector so ...

Edward’s Syndrome Treatment MarketThe global Edward’s syndrome treatment market is set for significant growth, with a projected market value of USD 7.98 Billion by 2033, according to a newly released ...

The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...

Teva receives a buy rating due to growth potential as a global generic drugmaker, despite high debt and legal/regulatory ...

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

Teva (TEVA) and Alvotech (ALVO) said the FDA has expanded labeling for its biosimilar of Stelara to include the treatment of ...

Iceland-based Alvotech and the US unit of Israel’s of Teva Pharmaceutical Industries today revealed that that the US Food and ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the FDA has ...